Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEO-ONE neoadjuvant hormonal therapy before brachytherapy in localized prostate cancer
2011-004749-41Phase 4Active
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
- Start
- Nov 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of leuprolide and bicalutamide in prostate cancer (PCa) (2 arms), sponsored by Elisabeth-TweeSteden Ziekenhuis. Primary endpoint: PSA levels. Started Nov 2011; status: active.
02
Drugs
leuprolidebicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2011-004749-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004749-41.